By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ViiV Healthcare 

Five Moore Drive

Research Triangle Park  North Carolina  27709-3398  U.S.A.
Phone: 877-844-8872 Fax: n/a


Company News
ViiV Healthcare Release: New Phase IIIb/IV Data Show Switching To Once-Daily Triumeq Maintains HIV Viral Suppression 9/23/2015 11:27:46 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall 7/9/2015 6:41:40 AM
ViiV Healthcare And Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply Of Dolutegravir In China And Several Developing Countries 7/2/2015 6:26:06 AM
ViiV Healthcare And CHAI Collaboration Delivers Second Milestone With First Filing With The FDA Of Generic Dolutegravir By Aurobindo Pharma (AUROBINDOP.BO) For The Treatment Of HIV 5/26/2015 7:31:55 AM
ViiV Healthcare Begins Phase III Programme With dolutegravir/rilpivirine Combination For HIV Maintenance Therapy 5/6/2015 6:25:33 AM
ViiV Healthcare Launches New Global Positive Action Program Focused On MSM & Transgender Population 3/31/2015 2:06:37 PM
ViiV Healthcare Wins for Corporate Reputation With Patients While Gilead (GILD) Freefalls Down List 2/16/2015 6:20:44 AM
ViiV Healthcare Announces $10 Million Initiative To Accelerate Response To HIV/AIDS Among Black Gay And Bisexual Men 2/4/2015 8:58:36 AM
Mylan Inc. (MYL) Receives Tentative FDA Approval For Pediatric Formulations Of abacavir/lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative 12/4/2014 12:02:58 PM
ViiV Healthcare Expands Program To Reduce HIV Disparities In Southern U.S. 10/20/2014 8:47:30 AM